Skip to content
  • About Us
    • About Epigral
    • Our Core Ethos
    • Board of Directors
    • Our Journey
    • R&D
    • Corporate Brochure
  • Products
    • Chlor Alkali
    • Chloromethanes
    • Hydrogen Peroxide
    • Epichlorohydrin
    • CPVC
    • Chlorotoluenes Value Chain
    • Product Flow Chart
  • Sustainability
    • Certifications
    • Environment Health and Safety
    • Corporate Social Responsibility
    • Sustainability Reports
  • Investors
    • Results
    • Information on Shareholders
    • Financial Snapshot and Graphs
    • Shareholding Pattern
    • Rating Rationale
    • Governance, Policies & Compliances
    • FAQs
    • Key Contacts
  • Media
    • Digital Domain
    • Print Chronicles
    • Television Broadcasts
  • Careers
  • Contact us
  • About Us
    • About Epigral
    • Our Core Ethos
    • Board of Directors
    • Our Journey
    • R&D
    • Corporate Brochure
  • Products
    • Chlor Alkali
    • Chloromethanes
    • Hydrogen Peroxide
    • Epichlorohydrin
    • CPVC
    • Chlorotoluenes Value Chain
    • Product Flow Chart
  • Sustainability
    • Certifications
    • Environment Health and Safety
    • Corporate Social Responsibility
    • Sustainability Reports
  • Investors
    • Results
    • Information on Shareholders
    • Financial Snapshot and Graphs
    • Shareholding Pattern
    • Rating Rationale
    • Governance, Policies & Compliances
    • FAQs
    • Key Contacts
  • Media
    • Digital Domain
    • Print Chronicles
    • Television Broadcasts
  • Careers
  • Contact us
  • About Us
    • About Epigral
    • Our Core Ethos
    • Board of Directors
    • Our Journey
    • R&D
    • Corporate Brochure
  • Products
    • Chlor Alkali
    • Chloromethanes
    • Hydrogen Peroxide
    • Epichlorohydrin
    • CPVC
    • Chlorotoluenes Value Chain
    • Product Flow Chart
  • Sustainability
    • Certifications
    • Environment Health and Safety
    • Corporate Social Responsibility
    • Sustainability Reports
  • Investors
    • Results
    • Information on Shareholders
    • Financial Snapshot and Graphs
    • Shareholding Pattern
    • Rating Rationale
    • Governance, Policies & Compliances
    • FAQs
    • Key Contacts
  • Media
    • Digital Domain
    • Print Chronicles
    • Television Broadcasts
  • Careers
  • Contact us
  • About Us
    • About Epigral
    • Our Core Ethos
    • Board of Directors
    • Our Journey
    • R&D
    • Corporate Brochure
  • Products
    • Chlor Alkali
    • Chloromethanes
    • Hydrogen Peroxide
    • Epichlorohydrin
    • CPVC
    • Chlorotoluenes Value Chain
    • Product Flow Chart
  • Sustainability
    • Certifications
    • Environment Health and Safety
    • Corporate Social Responsibility
    • Sustainability Reports
  • Investors
    • Results
    • Information on Shareholders
    • Financial Snapshot and Graphs
    • Shareholding Pattern
    • Rating Rationale
    • Governance, Policies & Compliances
    • FAQs
    • Key Contacts
  • Media
    • Digital Domain
    • Print Chronicles
    • Television Broadcasts
  • Careers
  • Contact us

Digital Domain

Explore the digital sphere, where we connect and share our narratives, innovations and industry perspectives through online platforms.

Meghmani Finechem Commissions Epichlorohydrin Plant

  • 1 June 2022

MFL to set up wind-solar hybrid project with ReNew Green Energy

  • 29 May 2022

Meghmani Finechem makes foray into green energy, to set up wind-solar project in Gujarat

  • 28 May 2022

Meghmani Finechem partners with Renew Green Energy

  • 28 May 2022

Meghmani Finechem reports surge in consolidated Q4FY22 PAT to Rs. 99.08 crores

  • 25 April 2022

Meghmani Finechem Q4 PAT up 3-fold to Rs99.09cr on subdued growth in raw material costs

  • 25 April 2022

Meghmani Finech Consolidated March 2022 Net Sales at Rs 498.80 crore, up 92.92% Y-o-Y

  • 25 April 2022

Meghmani Finechem consolidated net profit rises 202.47% in the March 2022 quarter

  • 25 April 2022

Meghmani Finechem Q4 results: PAT triples, backed by higher realisations

  • 25 April 2022

The demand and the way forward – Mr. Yash Chitnis, Vice President – Marketing.

  • 15 March 2022

Conversation with Mr. Maulik Patel, CMD, on performance and outlook for chemical industry

  • 3 February 2022

Interview with Mr. Maulik Patel, CMD, discussion on challenges, future capex and outlook

  • 3 February 2022

Mr. Maulik Patel, CMD, Pre-budget comment

  • 25 January 2022

Meghmani Finechem revenue rises 91% yoy to Rs422cr, PAT grows 184% yoy in Q3FY22

  • 24 January 2022

Meghmani Finechem standalone net profit rises 183.80% in the December 2021 quarter

  • 24 January 2022

Meghmani Finechem Q3 Results: Profit jumps 3 fold to Rs 69.68 crore

  • 24 January 2022

Mr. Maulik Patel, CMD, discussing about Alkali Chemicals – Crucial for Industries

  • 12 January 2022

Crisil upgrades Meghmani Finechem rating to AA-/Stable

  • 2 December 2021
Previous Page1 … Page3 Page4 Page5 Page6 Next

Explore our solutions – Connect with Epigral

Important Links

  • Chlor Alkali
  • Chloromethanes
  • Hydrogen Peroxide
  • Epichlorohydrin
  • Chlorotoluenes Value Chain
  • CPVC
  • About Us
  • Chlor Alkali
  • Chloromethanes
  • Hydrogen Peroxide
  • Epichlorohydrin
  • Chlorotoluenes Value Chain
  • CPVC
  • About Us

Quick Links

  • Results
  • Our Journey
  • Environment Health and Safety
  • Corporate Social Responsibility
  • Careers
  • Contact us
  • Results
  • Our Journey
  • Environment Health and Safety
  • Corporate Social Responsibility
  • Careers
  • Contact us

Contact

Monday-Saturday: 08am-9pm
+91 79 29709600

Want to email us instead?
in**@*****al.com

At Epigral, we are at the forefront of India’s chemical industry, bringing solutions by providing essential derivatives and specialty chemicals.

© 2023 Copyrights Epigral Limited. All Rights Reserved.